Tokyo Tape
Sign in
← M3

Quarterly report · Q1

2413.TEDINET S100OUDD
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥57.0bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥208.2bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥46.4bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥18.7bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥24.7bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥19.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥96.2bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥24.8bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥12.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥63.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥15.8bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥13.5bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥16.9bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥357.5bnat 2022-06-30Cons.Assets IFRS
Total assets¥346.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥272.0bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥82.4bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥82.0bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥275.1bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥264.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥211.6bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥207.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥268.8bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥257.8bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥206.2bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥88.8bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥104.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥79.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥89.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥9.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥52.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥8.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥14.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥23.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥6.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥12.5bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥16.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥17.862022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥94.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥23.232021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥17.852022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.982021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥23.212021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio75.2%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.8%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥471m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue external2022-04-01 → 2022-06-30¥5.2bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥267m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue2022-04-01 → 2022-06-30¥7.2bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥162m
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.2bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue2022-04-01 → 2022-06-30¥20.2bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue external2022-04-01 → 2022-06-30¥19.3bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥951m
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentsegment profit2022-04-01 → 2022-06-30¥8.8bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue2022-04-01 → 2022-06-30¥14.9bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue external2022-04-01 → 2022-06-30¥14.9bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥2m
jpcrp040300-q1r_E05425-000Overseasreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.0bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue2022-04-01 → 2022-06-30¥10.2bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue external2022-04-01 → 2022-06-30¥9.9bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥304m
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.4bn
—segment totalrevenue2022-04-01 → 2022-06-30¥58.0bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥56.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥1.7bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥19.3bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥947m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥947m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥144m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue2021-04-01 → 2021-06-30¥4.9bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue external2021-04-01 → 2021-06-30¥4.9bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥26m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.5bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue2021-04-01 → 2021-06-30¥4.8bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue external2021-04-01 → 2021-06-30¥4.6bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥195m
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentsegment profit2021-04-01 → 2021-06-30¥858m
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue2021-04-01 → 2021-06-30¥18.9bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue external2021-04-01 → 2021-06-30¥18.2bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥690m
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentsegment profit2021-04-01 → 2021-06-30¥8.2bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue external2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥12m
jpcrp040300-q1r_E05425-000Overseasreportable segmentsegment profit2021-04-01 → 2021-06-30¥13.0bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue2021-04-01 → 2021-06-30¥5.3bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue external2021-04-01 → 2021-06-30¥5.3bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentsegment profit2021-04-01 → 2021-06-30¥520m
—segment totalrevenue2021-04-01 → 2021-06-30¥46.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥45.7bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥923m
—segment totalsegment profit2021-04-01 → 2021-06-30¥25.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 594
ItemContextValueUnit
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-36000000JPY
Equity IFRSPrior1QuarterInstant_OtherComponentsOfEquityIFRSMember1639000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember144739000000JPY
Equity IFRSPrior1QuarterInstant_EquityAttributableToOwnersOfParentIFRSMember206166000000JPY
Equity IFRSPrior1QuarterInstant_NonControllingInterestsIFRSMember5423000000JPY
Equity IFRSPrior1QuarterInstant211590000000JPY
Equity IFRSPrior1YearInstant_ShareCapitalIFRSMember29129000000JPY
Equity IFRSPrior1YearInstant_CapitalSurplusIFRSMember29704000000JPY
Equity IFRSPrior1YearInstant_TreasurySharesIFRSMember-36000000JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember6131000000JPY
Equity IFRSPrior1YearInstant_RetainedEarningsIFRSMember192912000000JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember257840000000JPY
Equity IFRSPrior1YearInstant_NonControllingInterestsIFRSMember6113000000JPY
Equity IFRSPrior1YearInstant263954000000JPY
Profit loss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember12127000000JPY
Profit loss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember12127000000JPY
Profit loss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember1360000000JPY
Profit loss IFRSCurrentYTDDuration13487000000JPY
Other comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember9565000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember9565000000JPY
Other comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember208000000JPY
Other comprehensive income IFRSCurrentYTDDuration9773000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember9565000000JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember12127000000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember21692000000JPY
Comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember1568000000JPY
Comprehensive income IFRSCurrentYTDDuration23261000000JPY
Dividends ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-10862000000JPY
Dividends ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-10862000000JPY
Dividends ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-1790000000JPY
Dividends ss IFRSCurrentYTDDuration-12651000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember12000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember12000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember79000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember103000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration103000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-58000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember58000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration－JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember385000000JPY
Other ss IFRSCurrentYTDDuration385000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember12000000JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember12000000JPY
Total transactions with owners IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember21000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass